Updated: January 17, 2026
Alternatives to Gemtesa If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- How Gemtesa Works (Quick Recap)
- Alternative 1: Myrbetriq (Mirabegron) — Same Mechanism
- Alternative 2: Oxybutynin (Ditropan XL) — Affordable but More Side Effects
- Alternative 3: Solifenacin (VESIcare) — Once Daily Antimuscarinic
- Alternative 4: Tolterodine (Detrol) — Mild Side Effect Profile
- Side-by-Side Comparison
- Talking to Your Doctor About Switching
Can't fill your Gemtesa prescription due to cost or availability? Here are the best alternatives for overactive bladder and how they compare.
Gemtesa (vibegron) is an effective medication for overactive bladder (OAB), but not everyone can get it easily. Whether it's a cost barrier, insurance issues, or your pharmacy doesn't stock it, there are several legitimate alternatives worth discussing with your doctor.
This guide walks through the most commonly prescribed OAB alternatives to Gemtesa, how each works, what to expect in terms of side effects, and what they cost.
How Gemtesa Works (Quick Recap)
Gemtesa is a beta-3 adrenergic receptor agonist. It relaxes the detrusor smooth muscle in your bladder, allowing it to hold more urine before sending urgent signals to your brain. It does not block nerve signals — it simply calms the bladder muscle. It has a favorable side effect profile, does not affect blood pressure, and does not cause cognitive effects because it doesn't cross the blood-brain barrier.
Alternative 1: Myrbetriq (Mirabegron) — Same Mechanism
Best for: Patients who want a similar mechanism to Gemtesa with a lower cost option.
Mirabegron (Myrbetriq) is the most direct alternative to Gemtesa. Both are beta-3 adrenergic agonists that work by relaxing the bladder muscle. In head-to-head preference studies, patients generally showed similar efficacy between the two drugs, though slightly more patients preferred vibegron.
Key difference: A generic version of mirabegron extended-release became available in 2024, making it significantly more affordable. Mirabegron can elevate blood pressure in some patients, and it inhibits the CYP2D6 enzyme — meaning it may interact with a broader range of other medications than Gemtesa.
Dosing: 25 mg or 50 mg once daily (dose adjustment may be needed for liver or kidney problems). Cannot be crushed.
Alternative 2: Oxybutynin (Ditropan XL) — Affordable but More Side Effects
Best for: Patients who need the most affordable OAB treatment.
Oxybutynin is one of the oldest and most widely used OAB medications. It works as an anticholinergic (antimuscarinic), blocking nerve signals that cause bladder contractions. It's available in immediate-release tablets, extended-release tablets (Ditropan XL), a transdermal patch (Oxytrol), and a topical gel (Gelnique). Generic versions cost less than $10 per month with coupons.
The trade-off: Oxybutynin is well-known for anticholinergic side effects including dry mouth, constipation, blurred vision, and — particularly in older adults — confusion, memory problems, and drowsiness. The FDA's Beers Criteria lists anticholinergics like oxybutynin as potentially inappropriate for older adults.
Alternative 3: Solifenacin (VESIcare) — Once Daily Antimuscarinic
Best for: Patients looking for a once-daily antimuscarinic with a generic option.
Solifenacin (VESIcare) is a selective muscarinic receptor antagonist taken once daily in a 5 mg or 10 mg dose. A generic version is available, making it considerably less expensive than Gemtesa. Side effects are typical anticholinergic effects (dry mouth, constipation), though generally milder than oxybutynin. VESIcare LS (liquid suspension) is also available for patients who have difficulty swallowing tablets.
Alternative 4: Tolterodine (Detrol) — Mild Side Effect Profile
Best for: Patients who want an antimuscarinic with relatively mild side effects at low cost.
Tolterodine (Detrol) is available in immediate-release and extended-release (LA) formulations, with a well-tolerated side effect profile relative to other antimuscarinics. Generic tolterodine is widely available and affordable. It was used as the active comparator in the Gemtesa EMPOWUR Phase 3 trial, where Gemtesa significantly outperformed tolterodine in reducing urgency incontinence episodes at 52 weeks.
Side-by-Side Comparison
Here's a quick summary to help guide your conversation with your doctor:
Gemtesa (vibegron): Brand-only; ~$612–$692/month cash; minimal side effects; no cognitive effects; no BP elevation; no CYP2D6 interactions
Mirabegron ER (generic): Generic available (2024); lower cost; may raise BP; inhibits CYP2D6
Generic oxybutynin: Very affordable (<$10/month); multiple forms; significant dry mouth/constipation/cognitive effects
Generic solifenacin: Once daily; affordable; moderate anticholinergic side effects
Generic tolterodine: Affordable; milder anticholinergic effects than oxybutynin
Talking to Your Doctor About Switching
Before switching medications, talk to your prescriber about why you're having trouble getting Gemtesa. There may be a coverage or access solution you haven't tried yet — see How to Find Gemtesa in Stock Near You. But if access is truly not possible, any of the alternatives above are medically recognized treatments for OAB. Bring your side effect history, cost concerns, and other medications you take so your doctor can make the best recommendation for you.
Frequently Asked Questions
The most similar medication to Gemtesa (vibegron) is Myrbetriq (mirabegron). Both are beta-3 adrenergic agonists that relax bladder muscle through the same mechanism. A generic version of mirabegron ER became available in 2024, making it more affordable. Key differences: mirabegron may raise blood pressure and has more drug interactions than Gemtesa.
Yes. Generic mirabegron ER (available since 2024) is a lower-cost beta-3 agonist alternative. Generic anticholinergics like oxybutynin, solifenacin, and tolterodine are even more affordable, often under $30/month with coupons. These work differently from Gemtesa and may have more side effects, especially for older adults.
Yes, with your doctor's guidance. Oxybutynin is a widely available antimuscarinic for OAB. It works differently from Gemtesa and has a higher risk of anticholinergic side effects like dry mouth, constipation, and cognitive effects — particularly in older adults. Your doctor can help determine if switching is appropriate based on your health history.
Gemtesa and mirabegron have similar efficacy for OAB. In comparative studies, both significantly improved urgency, frequency, and incontinence episodes. A 2023 head-to-head study found similar outcomes, though slightly more patients preferred vibegron. Your prescriber can help you weigh the options based on your specific situation and other medications.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Gemtesa also looked for:
More about Gemtesa
31,889 have already found their meds with Medfinder.
Start your search today.





